What does elutia (cormatrix) — financial royalty assets, net mean?

This is the carrying value of royalty assets for the Elutia and CorMatrix segments after deducting the allowance for credit losses. It represents the net economic value the company expects to recover from these specific royalty streams. This figure is critical for assessing the current fair value and liquidity potential of the company's intellectual property portfolio.

Ligand Pharmaceuticals LGND Elutia (CorMatrix) — Financial Royalty Assets, Net

Other product segments

Qarziba

$103.24M—

Similar metrics at other companies

NOVRoyalty — Contract With Customer Receivable After Allowance For Credit Loss

$43M+231%

UTHRUnituxin — Royalty as a percentage of net sales

0.3%0.0pp

RGLDRoyalty interest — Stream and royalty interests, net (Note 3)

$4.06B—

BBIODeferred royalty obligations, net

$871.19M+75.2%

RGLDEMEA — Stream and royalty interests, net (Note 3)

$2.56B—

MCReceivables Net

$125.29M+34.2%

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.51B+96.7%

Enterprise value$5.4B+95.4%

P/E35.9×—

P/S20.1×+4.6×

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept lgnd:FinancialRoyaltyAssetsNet.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's elutia (cormatrix) — financial royalty assets, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's elutia (cormatrix) — financial royalty assets, net?: Ligand Pharmaceuticals (LGND) reported elutia (cormatrix) — financial royalty assets, net of $5.78M in Q1 2026.
What does elutia (cormatrix) — financial royalty assets, net mean?: This is the carrying value of royalty assets for the Elutia and CorMatrix segments after deducting the allowance for credit losses. It represents the net economic value the company expects to recover from these specific royalty streams. This figure is critical for assessing the current fair value and liquidity potential of the company's intellectual property portfolio.